Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
BeiGene
BeiGene
AbbVie
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)